Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Isosorbide dinitrate 25mg/50ml solution for infusion bottles
0206010I0AAAYAY
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 25mg/50ml solution for infusion vials
0206010I0AAAZAZ
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 30mg tablets
0206010I0AAAFAF
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 30mg/5ml oral liquid
0206010I0AAAWAW
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 30mg/dose transdermal spray
0206010I0AAAUAU
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 40mg modified-release capsules
0206010I0AAABAB
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 40mg/5ml oral liquid
0206010I0AAASAS
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 50mg/50ml solution for infusion vials
0206010I0AABABA
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide dinitrate 5mg/5ml oral liquid
0206010I0AAATAT
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 10mg/5ml oral liquid
0206010K0AAANAN
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 15mg/5ml oral solution
0206010K0AAASAS
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 30mg modified-release tablets
0206010K0AABDBD
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 30mg/5ml oral liquid
0206010K0AAARAR
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 40mg/5ml oral solution
0206010K0AAAMAM
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 60mg/5ml oral solution
0206010K0AAAWAW
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isradipine 2.5mg tablets
0206020I0AAAAAA
|
Isradipine | Isradipine | Cardiovascular System | No data available |
|
Kalten capsules
0204000F0BBAAAA
|
Kalten | Atenolol with diuretic | Cardiovascular System | No data available |
|
Kaplon 12.5mg tablets
0205051F0BFAAAD
|
Kaplon | Captopril | Cardiovascular System | No data available |
|
Kaplon 25mg tablets
0205051F0BFABAE
|
Kaplon | Captopril | Cardiovascular System | No data available |
|
Kaplon 50mg tablets
0205051F0BFACAF
|
Kaplon | Captopril | Cardiovascular System | No data available |
|
Keloc SR 10mg tablets
0206020F0BHABAC
|
Keloc | Felodipine | Cardiovascular System | No data available |
|
Keloc SR 5mg tablets
0206020F0BHAAAB
|
Keloc | Felodipine | Cardiovascular System | No data available |
|
Kentipine MR 10 tablets
0206020R0BKADAE
|
Kentipine | Nifedipine | Cardiovascular System | No data available |
|
Kentipine MR 20 tablets
0206020R0BKACAR
|
Kentipine | Nifedipine | Cardiovascular System | No data available |
|
Kenzem SR 90mg capsules
0206020C0BYABAT
|
Kenzem | Diltiazem hydrochloride | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.